• | Consolidated net sales increased 18.9% to $104.9 million, as a result of double-digit growth in both premium beverage alcohol and the Ingredient Solutions segment. |
• | Consolidated gross profit increased 31.2% to $25.6 million, as gross profit improved in both the Distillery Products and Ingredient Solutions segments. |
• | Consolidated operating income increased 57.7% to $16.6 million, reflecting net sales gains and gross profit growth in both segments. |
• | Earnings per share decreased to $0.69 per share from $0.74 per share in the prior-year period, due to a deferred tax liability revaluation benefit recorded in the fourth quarter of 2017 resulting from the Tax Cuts and Jobs Act. |
• | Consolidated net sales increased 8.2% to $376.1 million, as a result of growth in both the Distillery Products and Ingredient Solutions segments. |
• | Consolidated gross profit increased 10.0% to $83.6 million, reflecting improved results in the Distillery Products and Ingredient Solutions segments. |
• | Consolidated operating income increased 16.9% to $50.1 million, as a result of strong sales growth and improved operating performance in both the Distillery Products and Ingredient Solutions segments. |
• | Earnings per share were $2.17 per share compared to $2.44 per share in the prior-year period, primarily due to the 2017 net gain on the sale of ICP and the deferred tax liability revaluation benefit, which offset strong gains in operating performance in the current year. |
Premium Beverage Alcohol (in thousands) | Net Sales Quarter Ended December 31, | Quarter vs. Quarter Net Sales Change Increase/(Decrease) | |||||||||||||
2018 | 2017 | $ Change | % Change | ||||||||||||
Brown Goods | $ | 37,784 | $ | 28,818 | $ | 8,966 | 31.1 | % | |||||||
White Goods | 17,512 | 17,312 | 200 | 1.2 | |||||||||||
Premium Beverage Alcohol | $ | 55,296 | $ | 46,130 | $ | 9,166 | 19.9 | % |
Premium Beverage Alcohol (in thousands) | Net Sales Year Ended December 31, | Year vs. Year Net Sales Change Increase/(Decrease) | |||||||||||||
2018 | 2017 | $ Change | % Change | ||||||||||||
Brown Goods | $ | 125,857 | $ | 113,413 | $ | 12,444 | 11.0 | % | |||||||
White Goods | 62,574 | 64,585 | (2,011 | ) | (3.1 | ) | |||||||||
Premium Beverage Alcohol | $ | 188,431 | $ | 177,998 | $ | 10,433 | 5.9 | % |
• | 2019 net sales growth is projected in the mid-single-digit percentage range versus 2018, subject to some volatility due to the current conditions in the industrial alcohol market. |
• | 2019 gross margins are expected to increase modestly as compared to 2018. |
• | The Company’s estimate of growth in operating income in 2019 is 15% to 20% off of the higher than expected 2018 results. |
• | 2019 effective tax rate is forecasted to be approximately 21%, and shares outstanding are expected to be approximately 17 million at year end. |
• | Earnings per share are forecasted to be in the $2.55 to $2.65 range. |
Operating income | Operating Income | Change Quarter-versus-Quarter | ||||||
Operating income for the quarter ended December 31, 2017 | $ | 10,532 | ||||||
Increase in gross profit - distillery products segment | 5,225 | 49.6 | pp(a) | |||||
Increase in gross profit - ingredient solutions segment | 858 | 8.1 | pp | |||||
Change in SG&A expenses | (3 | ) | — | pp | ||||
Operating income for the quarter ended December 31, 2018 | $ | 16,612 | 57.7 | % |
Operating income | Operating Income | Change Year-versus-Year | ||||||
Operating income for 2017 | $ | 42,909 | ||||||
Increase in gross profit - distillery products segment | 4,976 | 11.6 | pp(a) | |||||
Increase in gross profit - ingredient solutions segment | 2,607 | 6.1 | pp | |||||
Change in SG&A expenses | (344 | ) | (0.8 | ) | pp | |||
Operating income for 2018 | $ | 50,148 | 16.9 | % |
Change in basic and diluted earnings per share | Basic and Diluted EPS | Change Quarter-versus-Quarter | ||||||
Basic and diluted earnings per share for the quarter ended December 31, 2017 | $ | 0.74 | ||||||
Change in operations(a) | 0.22 | 29.7 | pp(b) | |||||
Change in weighted average shares outstanding(c) | (0.01 | ) | (1.3 | ) | pp | |||
Tax: Effect of Tax Act on deferred tax attributes(d) | (0.19 | ) | (25.7 | ) | pp | |||
Tax: Change in discrete items (excluding effect of Tax Act) | (0.19 | ) | (25.7 | ) | pp | |||
Tax: Change in effective tax rate (excluding tax item above) | 0.12 | 16.2 | pp | |||||
Basic and diluted earnings per share for the quarter ended December 31, 2018 | $ | 0.69 | (6.8 | )% |
(a) | Items are net of tax based on the effective tax rate for the base year quarter (2017), excluding the effect of the Tax Act on deferred tax attributes and the change in other discrete tax items. |
(b) | Percentage points ("pp"). |
(c) | Weighted average shares outstanding change primarily due to the vesting of employee RSUs, the granting of Common Stock to directors, our purchase of vested RSUs from employees to pay withholding taxes, and our repurchases of Common Stock. |
(d) | On December 22, 2017, the United States enacted tax reform legislation, the Tax Cuts and Jobs Act (the "Tax Act"), that resulted in significant modifications to existing law. Following guidance in SAB 118, we recorded a provisional discrete net tax benefit resulting from the revaluation of our deferred income taxes in 2017. The accounting for the Tax Act was completed in 2018 and the discrete net benefit recorded in 2017 is no longer provisional. |
Change in basic and diluted earnings per share | Basic and Diluted EPS | Change Year-versus-Year | ||||||
Basic and diluted earnings per share for 2017 | $ | 2.44 | ||||||
Change in operations(a) | 0.27 | 11.1 | pp(b) | |||||
Gain on sale of equity method investment(c) | (0.44 | ) | (18.0 | ) | pp | |||
Change in equity method investment(a) | 0.01 | 0.4 | pp | |||||
Change in income attributable to participating securities(d) | 0.02 | 0.8 | pp | |||||
Change in weighted average shares outstanding(d) | (0.01 | ) | (0.4 | ) | pp | |||
Tax: Effect of Tax Act on deferred tax attributes(e) | (0.19 | ) | (7.8 | ) | pp | |||
Tax: Change in discrete items (excluding effect of Tax Act) | (0.30 | ) | (12.3 | ) | pp | |||
Tax: Change in effective tax rate (excluding tax items above) | 0.37 | 15.1 | pp | |||||
Basic and diluted earnings per share for 2018 | $ | 2.17 | (11.1 | )% |
(a) | Items are net of tax based on the effective tax rate for the base year (2017), excluding the effect of the Tax Act on deferred tax attributes and the change in other discrete tax items. |
(b) | Percentage points ("pp") |
(c) | Item is net of tax based on the effective tax rate for the transaction. |
(e) | On December 22, 2017, the United States enacted tax reform legislation, the Tax Act, that resulted in significant modifications to existing law. Following guidance in SAB 118, we recorded a provisional discrete net tax benefit resulting from the revaluation of our deferred income taxes in 2017. The accounting for the Tax Act was completed in 2018 and the discrete net benefit recorded in 2017 is no longer provisional. |
Quarter Ended | Year Ended | |||||||||||||||
December 31, 2018 | December 31, 2017 | December 31, 2018 | December 31, 2017 | |||||||||||||
Net sales | $ | 104,850 | $ | 88,193 | $ | 376,089 | $ | 347,448 | ||||||||
Cost of sales | 79,242 | 68,668 | 292,490 | 271,432 | ||||||||||||
Gross profit | 25,608 | 19,525 | 83,599 | 76,016 | ||||||||||||
Selling, general and administrative expenses | 8,996 | 8,993 | 33,451 | 33,107 | ||||||||||||
Other operating income, net | — | — | — | — | ||||||||||||
Operating income | 16,612 | 10,532 | 50,148 | 42,909 | ||||||||||||
Gain on sale of equity method investment | — | — | — | 11,381 | ||||||||||||
Equity method investment loss | — | — | — | (348 | ) | |||||||||||
Interest expense, net | (338 | ) | (250 | ) | (1,168 | ) | (1,184 | ) | ||||||||
Income before income taxes | 16,274 | 10,282 | 48,980 | 52,758 | ||||||||||||
Income tax expense (benefit) | 4,452 | (2,357 | ) | 11,696 | 10,935 | |||||||||||
Net income | $ | 11,822 | $ | 12,639 | 37,284 | $ | 41,823 | |||||||||
Income attributable to participating securities | 224 | 275 | 708 | 996 | ||||||||||||
Net income attributable to common shareholders and used in EPS calculation | $ | 11,598 | $ | 12,364 | $ | 36,576 | $ | 40,827 | ||||||||
Share information: | ||||||||||||||||
Diluted weighted average common shares | 16,879,503 | 16,780,430 | 16,866,176 | 16,746,731 | ||||||||||||
Basic and diluted earnings per common share | $ | 0.69 | $ | 0.74 | $ | 2.17 | $ | 2.44 | ||||||||
Dividends and dividend equivalents per common share | $ | 0.08 | $ | 0.04 | $ | 0.32 | $ | 1.01 |
(Dollars in thousands) | December 31, 2018 | December 31, 2017 | (Dollars in thousands) | December 31, 2018 | December 31, 2017 | |||||||||||
ASSETS | LIABILITIES AND STOCKHOLDERS’ EQUITY | |||||||||||||||
Current Assets: | Current Liabilities: | |||||||||||||||
Cash and cash equivalents | $ | 5,025 | $ | 3,084 | Current maturities of long-term debt | $ | 386 | $ | 372 | |||||||
Receivables, net | 38,797 | 34,347 | Accounts payable | 25,363 | 30,037 | |||||||||||
Inventory | 108,769 | 93,149 | Accrued expenses | 11,714 | 11,171 | |||||||||||
Prepaid expenses | 1,320 | 2,182 | ||||||||||||||
Refundable income taxes | 712 | 1,980 | ||||||||||||||
Total Current Assets | 154,623 | 134,742 | Total Current Liabilities | 37,463 | 41,580 | |||||||||||
Other Liabilities: | ||||||||||||||||
Long-term debt, less current maturities | 21,040 | 21,407 | ||||||||||||||
Credit agreement - revolver | 10,588 | 2,775 | ||||||||||||||
Property and equipment | 295,893 | 267,288 | Deferred credits | 1,565 | 2,151 | |||||||||||
Less accumulated depreciation and amortization | (175,105 | ) | (164,237 | ) | Accrued retirement, health, and life insurance benefits | 2,595 | 3,133 | |||||||||
Other noncurrent liabilities | 1,523 | 540 | ||||||||||||||
Net Property, Plant, and Equipment | 120,788 | 103,051 | Deferred income taxes | 1,677 | 12 | |||||||||||
Other assets | 2,481 | 2,535 | Total Liabilities | 76,451 | 71,598 | |||||||||||
Stockholders’ equity | 201,441 | 168,730 | ||||||||||||||
TOTAL ASSETS | $ | 277,892 | $ | 240,328 | TOTAL LIABILITIES AND STOCKHOLDERS’ EQUITY | $ | 277,892 | $ | 240,328 |
Year to Date Ended | ||||||||
December 31, 2018 | December 31, 2017 | |||||||
Cash Flows from Operating Activities | ||||||||
Net income | $ | 37,284 | $ | 41,823 | ||||
Adjustments to reconcile net income to net cash provided by operating activities: | ||||||||
Depreciation and amortization | 11,362 | 11,308 | ||||||
Gain on sale of equity method investment | — | (11,381 | ) | |||||
Share-based compensation | 3,099 | 2,574 | ||||||
Equity method investment (earnings) loss | — | 348 | ||||||
Distributions received from equity method investee | — | 7,131 | ||||||
Deferred income taxes, including change in valuation allowance | 1,665 | (3,420 | ) | |||||
Other, net | — | 61 | ||||||
Changes in operating assets and liabilities: | ||||||||
Receivables, net | (4,450 | ) | (8,262 | ) | ||||
Inventory | (15,620 | ) | (14,291 | ) | ||||
Prepaid expenses | 862 | (498 | ) | |||||
Refundable income taxes | 1,268 | 725 | ||||||
Accounts payable | (2,542 | ) | 9,540 | |||||
Accounts payable to affiliate, net | — | (3,349 | ) | |||||
Accrued expenses | 551 | 2,278 | ||||||
Deferred credits | (586 | ) | (827 | ) | ||||
Accrued retirement, health, and life insurance benefits | 588 | (289 | ) | |||||
Net cash provided by operating activities | 33,481 | 33,471 | ||||||
Cash Flows from Investing Activities | ||||||||
Additions to property, plant, and equipment | (31,046 | ) | (21,055 | ) | ||||
Divestiture of equity method investment, net | — | 22,832 | ||||||
Net cash provided by (used in) investing activities | (31,046 | ) | 1,777 | |||||
Cash Flows from Financing Activities | ||||||||
Payment of dividends and dividend equivalents | (5,500 | ) | (17,380 | ) | ||||
Purchase of treasury stock for tax withholding on equity-based compensation | (2,324 | ) | (4,663 | ) | ||||
Loan fees incurred with borrowings | — | (377 | ) | |||||
Principal payments on long-term debt | (372 | ) | (358 | ) | ||||
Proceeds on long-term debt | — | 20,000 | ||||||
Proceeds from credit agreement - revolver | 28,966 | 25,930 | ||||||
Payments on credit agreement - revolver | (21,264 | ) | (56,885 | ) | ||||
Net cash used in financing activities | (494 | ) | (33,733 | ) | ||||
Increase in cash | 1,941 | 1,515 | ||||||
Cash, beginning of year | 3,084 | 1,569 | ||||||
Cash, end of year | $ | 5,025 | $ | 3,084 |